ERBB2 and breast neoplasm: Streptavidin-conjugated QDs were first used for imaging of the tumor marker HER2/neu on the surface of human breast tumor SKBR-3 cells through biotin-conjugated anti-human secondary antibodies and humanized anti-HER2/neu antibodies [16].